Table 3.
Serum metabolites significantly differing between non-diabetes control participants and participants with type 1 diabetes at rest (baseline)
| Metabolite | Fold change | Log2(fold change) | p value |
|---|---|---|---|
| NEFA C22:0 | 1.6834 | 0.75142 | 3.63×10−8 |
| Lactic acid | 1.2215 | 0.28862 | 1.23×10−5 |
| NEFA C20:0 | 1.6568 | 0.72838 | 4.45×10−5 |
| Succinate | 1.3117 | 0.39145 | 0.00011 |
| Malic acid | 1.3939 | 0.47913 | 0.00116 |
| BAIBA | 0.65902 | −0.60161 | 0.001335 |
| AC C18:1 | 1.5043 | 0.58909 | 0.001857 |
| AC C16:1 | 1.724 | 0.78579 | 0.003675 |
| Taurohyodeoxycholic acid | 0.2695 | −1.8917 | 0.020038 |
| cis-Aconitate | 1.5488 | 0.63113 | 0.025681 |
| cAMP | 1.4947 | 0.57985 | 0.044342 |
The table shows the fold change and log2(fold change) of metabolites in the serum of participants with type 1 diabetes compared with control participants at the baseline time point of the aerobic exercise study (n=30 for both groups)
p value was generated by two-tailed Student’s t test